Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.18 - $1.74 $2,473 - $3,647
-2,096 Reduced 13.83%
13,057 $22,000
Q1 2024

May 15, 2024

BUY
$1.47 - $2.03 $22,274 - $30,760
15,153 New
15,153 $23,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.